33 results
424B5
BIVI
BioVie Inc - Ordinary Shares
4 Mar 24
Prospectus supplement for primary offering
5:28pm
, results of operations and prospects.
In 2012, the European Patent Package, or EU Patent Package, regulations were passed with the goal of providing … Patent Package occurred in 2023. Under the UPC, all European patents, including those issued prior to ratification of the European Patent Package
8-K
EX-10.1
BIVI
BioVie Inc - Ordinary Shares
4 Mar 24
BioVie Inc. Announces Proposed Public Offering of Common Stock
7:50am
, on the date of this Agreement.
“Disclosure Package” means the Preliminary Prospectus dated March 1, 2024, together with the pricing terms and other … as described in the Registration Statement, the Disclosure Package and the Prospectus. The Company has submitted the Listing of Additional Shares
424B5
BIVI
BioVie Inc - Ordinary Shares
1 Mar 24
Prospectus supplement for primary offering
5:27pm
.
In 2012, the European Patent Package, or EU Patent Package, regulations were passed with the goal of providing a single pan-European Unitary Patent … and a new European Unified Patent Court (“UPC”), for litigation involving European patents. Implementation of the EU Patent Package occurred in 2023
424B5
BIVI
BioVie Inc - Ordinary Shares
6 Apr 23
Prospectus supplement for primary offering
5:46pm
a Type B Meeting and subsequently submitted an extensive pre-meeting information package. In April 2020, the FDA provided a written response
424B5
34jn5cu pi
23 Dec 22
Prospectus supplement for primary offering
5:15pm
424B5
m1zb0k1cdw 5lfxgz2
14 Dec 22
Prospectus supplement for primary offering
8:25pm
424B5
ozepw7t0at0wxb0
31 Aug 22
Prospectus supplement for primary offering
5:10pm
8-K
EX-1.1
i5uy8qhtwyn3q0h95
11 Aug 21
BioVie Inc. Announces Pricing of Public Offering of Common Stock
1:23pm
424B5
hpj8sc
10 Aug 21
Prospectus supplement for primary offering
12:00am
424B5
hkvr3x 79
6 Aug 21
Prospectus supplement for primary offering
5:21pm
DEFM14C
c7pv3w5jgiqkme9 r6ra
20 May 21
Information related to merger
4:47pm
PRER14C
w4ldx390
10 May 21
Preliminary revised information
4:44pm
PREM14C
ofzyrlh
4 May 21
Preliminary information related to merger
5:23pm
8-K
EX-2.1
vin37s i7eg3
27 Apr 21
BioVie Acquires Biopharma Assets from Privately Held NeurMedix
5:19pm